Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New balance training could cut fall risk for seniors with brain circulation issues

NCT ID NCT07358338

Disease control Sponsor: Litvina Lyubov Dmitrievna Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether two biofeedback devices—a balance platform (Huber) and a smart treadmill (C-Mill)—can improve balance and reduce fall risk in 120 older adults (65+) with chronic cerebral ischemia. Participants will do 8 sessions of training, and researchers will compare their fall risk, balance, and cognitive function to a control group doing standard exercises. The goal is to see if these high-tech tools are better than regular therapy for preventing falls.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Biofeedback training devices (Huber stabilizer and C-Mill treadmill)
What this could lead to
If successful, this could provide a new, non-drug way to improve balance and reduce falls in older adults with chronic brain circulation problems.
What could go wrong
This is a small, early-stage study with 120 participants, so results may not apply to everyone. The devices are not widely available, and benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

120 people

The number who actually took part.

Started

Jun 2025

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 to 98 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Elderly people aged 65 years and older, with a diagnosis of "Chronic cerebral ischemia" (according to the ICD-10 classification - I67.8 Other specified cerebral vascular lesions), atherosclerotic/hypertensive/mixed genesis (E.I. Gusev et al. 2022), clinical stage 1 or 2 according to the guidelines of the Research Institute of Neurology of the Russian Academy of Medical Sciences (2001) with neuroimaging-confirmed structural damage to the brain (stage 1 according to O.S. Levin (2006) 2. Signed voluntary consent to participate in the study. Exclusion Criteria: 1. Age under 65, age over 98 2. Chronic diseases in the decompensation stage 3. Severe cognitive impairment 4. History of acute cerebrovascular accident 5. Presence of hemodynamically significant stenosis of the main cerebral arteries 6. Uncontrolled arterial hypertension 7. Neurodegenerative diseases 8. Dysmetabolic encephalopathy 9. History of traumatic brain injury 10. Condition after endoprosthetics of large joints 11. Severe sarcopenia 12. Oncological diseases in the progression stage 13. Lack of informed consent of the patient for the conduct of the study and access to information.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Accidental fall are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

brain ischemia cerebrovascular disorder Gait Disorders, Neurologic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Accidental fall Aged Cerebrovascular disorders Gait disorders, neurologic Postural balance

Contacts and locations

Locations

  • MEDSI Clinic

    Moscow, 143442, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.